EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME by A. V. Rudakova, N. V. Lomakin

Get full text

EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME by A. V. Rudakova, N. V. Lomakin

Get full text

Thrombocytopenia and prospective endovascular intervention in a patient with coronary artery disease by A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin

Get full text

Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding by A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin

Get full text

A Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Di... by N. V. Lomakin, L. I. Buryachkovskaya, D. A. Zolin, V. I. Kazey

Get full text

Effect of lornoxicam on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome by Nikita Valer'evich Lomakin, Aleksey Kirillovich Gruzdev, N V Lomakin, A K Gruzdev

Get full text

Clinical Significance of Thrombin Blockade with Low Doses (2.5 mg) of Rivaroxaban in Ischemic Heart Disease Patients by A. B. Sumarokov, L. I. Buryachkovskaya, Y. V. Docenko, M. S. Kurochkin, N. V. Lomakin

Get full text

INDIVIDUAL APPROACH TO PATIENTS WITH INDICATION FOR ANTIPLATELET THERAPY. WHAT TO RELY ON IN CHOOSING THE THERAPY? by N. V. LOMAKIN, A. B. SUMAROKOV, Yu. V. DOTSENKO, I. A. UCHITEL, L. I. BURYACHKOVSKAYA

Get full text

Sulodexide as pharmacotherapy for protection of endothelium and suppression of thrombosis in COVID-19 by A. M. Melkumyants, L. I. Buryachkovskaya, N. V. Lomakin, O. A. Antonova, V. V. Ermiskin, Y. V. Dotsenko

Get full text

The resolution of the Expert Council on current issues of the use of acetylsalicylic acid for the purpose of primary prevention of cardiovascular diseases in the light of new scien... by O. M. Drapkina, T. V. Vavilova, Yu. A. Karpov, Zh. D. Kobalava, N. V. Lomakin, А. I. Martynov, E. V. Roitman, D. A. Sychev

Get full text

Levilimab clinical efficacy for interleukin-6 receptor inhibition in COVID-19 and its potential for treating cytokine release syndrome of other aetiologies by N. V. Lomakin, B. A. Bakirov, G. H. Musaev, V. V. Popov, E. A. Smolyarchuk, Yu. N. Linkova, D. V. Bogdan, A. V. Eremeeva, P. S. Pukhtinskaia, M. A. Morozova, A. V. Zinkina-Orikhan, A. A. Lutckii

Get full text